Mappel doesn't want to supply US after warning letter
Mappel Indústria de Embalagens says it did not know the US would regulate the dermacosmetic products made at its Sao Paulo plant as OTC drugs after FDA warning.
Archives for October 6, 2016
Dispatches from CPhI Worldwide
UK-based CMOs benefitting from currency exchange post-Brexit vote
UK-based contract manufacturers are benefitting from the weak pound following the country’s referendum in June, but the long-term impact of Brexit is still unknown.
Nippon staff formed barrier to block QC lab inspection says US FDA
Nippon Fine Chemical staff formed a human barricade to prevent a US FDA team inspecting a quality control laboratory at its site in Takasago City, Japan according to a warning letter published this week.
Merck opens testing plant in latest Korean bioprocessing investment
Germany’s Merck has opened a bioprocessing collaboration centre in Songdo, Incheon - the latest investment supporting the burgeoning Korean biopharma industry.
Lupin to develop ADHD formulations using MonoSol Rx film tech
MonoSol Rx has licensed development rights to its film drug delivery technology to Lupin Pharmaceutical.